Evidence map›Paper›PMID 41167680›Full record

Observational studyIn vivo (Athens, Greece)

Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in Germany.

Johanna Ernst, Katharina Alfter, Alexander Mustea, Andree Faridi, Tim Glowka, Ulrich Herrlinger, Sebastian Koob, Thore Thiesler, Frederick Far, Torsten Pietsch and 13 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Johanna Ernst *Department of Integrated Oncology - CIO Bonn, University Hospital Bonn, Bonn, Germany.
Katharina Alfter *Department of Integrated Oncology - CIO Bonn, University Hospital Bonn, Bonn, Germany.
Alexander MusteaDepartment of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
Andree FaridiDepartment of Senology, University Hospital Bonn, Bonn, Germany.
Tim GlowkaDepartment of Surgery, University Hospital Bonn, Bonn, Germany.
Ulrich HerrlingerDepartment of Neurooncology, Center for Integrated Oncology, University of Bonn, Bonn, Germany.
Sebastian KoobDepartment of Orthopedics and Trauma Surgery, University Hospital Bonn, Bonn, Germany.
Thore ThieslerInstitute for Pathology, University Hospital Bonn, Bonn, Germany.
Frederick FarDepartment of Oral, Maxillofacial and Plastic Surgery, University Hospital Bonn, Bonn, Germany.
Torsten PietschDepartment of Neuropathology, University Hospital Bonn, Bonn, Germany.
Ulrike AttenbergerDepartment of Radiology, University Hospital Bonn, Bonn, Germany.
Nicole ErnstmannCenter for Health Communication and Health Services Research, Department of Psychosomatic Medicine and Psychotherapy, University Hospital Bonn, Bonn, Germany.
Jennifer LandsbergDepartment of Dermatology and Dermatological Oncology, University Hospital Bonn, Bonn, Germany.
Markus EsslerDepartment of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
Manuel RitterDepartment of Urology, University Hospital Bonn, Bonn, Germany.
Stefan HauserDepartment of Urology, University Hospital Bonn, Bonn, Germany.
Georg FeldmannDepartment of Haematology and Oncology, University Hospital Bonn, Bonn, Germany.
Franz Georg BauernfeindDepartment of Haematology and Oncology, University Hospital Bonn, Bonn, Germany.
Stefan AretzInstitute for Human Genetics and National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
Maria Gonzalez-CarmonaDepartment of Internal Medicine 1, Oncologic Gastroenterology, University Hospital Bonn, Bonn, Germany.
Matthias SchmidInstitute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.
Amit SharmaDepartment of Integrated Oncology - CIO Bonn, University Hospital Bonn, Bonn, Germany.
Ingo G H Schmidt-WolfDepartment of Integrated Oncology - CIO Bonn, University Hospital Bonn, Bonn, Germany; Ingo.Schmidt-Wolf@ukbonn.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimTumor boards (TUBs) are interdisciplinary meetings designed to determine the most effective cancer therapies and improve patient outcomes. This study aimed to assess which TUB therapy recommendations were easily implemented and to identify factors that hindered their implementation in clinical practice. PATIENTS AND

methodsIn this retrospective study, data from ten TUBs held at the University Hospital Bonn between 2014 and 2016 were analyzed. The dataset included 7,152 patients and 13,050 therapy recommendations. The degree of adherence to the recommended therapies was classified into four categories. Additionally, reasons for deviations from the recommendations were categorized based on medical record reviews.

resultsOn average, 84.2% of recommendations were implemented: 68.1% were fully and 16.1% partially implemented. Deviations occurred in 8.6% of cases. The most common reasons for partial implementation were therapy changes based on new clinical findings or physician decisions (16.7%) and patient preferences (10.4%). The leading reason for complete deviation from the recommendation was lack of documentation (51.3%).

conclusionMost TUB recommendations across ten medical disciplines were fully or partially implemented. However, there remains potential for improvement, particularly in ensuring consistent documentation and integrating patient preferences into clinical decision-making.

Indexed as

Clinical Decision-MakingNeoplasmsAgedFemaleGermanyHumansMaleMiddle AgedRetrospective Studiesadherencedevianceimplementation ratetherapy recommendationsTumor board

Identifiers

PMID41167680
PMCPMC12588192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.